Eli Lilly | 판매 및 관리 비용



Selling And Administration Expenses 변화 날짜
AbbVie USD 3.25B 40M 2025-06
Abbott USD 3.09B 39M 2025-06
ALKERMES USD 153.87M 17.83M 2025-06
Amgen USD 1.69B 4M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Baxter International USD 718M 15M 2025-06
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Drreddys Laboratories INR 23.18B 1.59B 2025-06
Eli Lilly USD 2.75B 390.8M 2025-06
Gilead Sciences USD 1.36B 100M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
Glaxosmithkline GBP 2.09B 609M 2025-06
J&J USD 5.89B 777M 2025-06
Medtronic USD 2.81B 106M 2025-07
Merck USD 2.63B 104M 2025-06
Neurocrine Biosciences USD 286.3M 9.8M 2025-06
Novartis USD 3.44B 384M 2025-06
Novartis USD 3.44B 60M 2025-06
Novo Nordisk 18.85B 2.74B 2025-06
Perrigo USD 273.1M 8.1M 2025-06
Pfizer USD 3.42B 406M 2025-06
Prestige Brands USD 28.46M 35.6M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.63B 408M 2025-06
Sanofi EUR 2.32B 1.08B 2025-06
United Therapeutics USD 212.5M 42.4M 2025-06
Zoetis USD 617M 54M 2025-06


Eli Lilly 판매 및 관리 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Sep 2025.